Home / BusinessCNBCBusinessCNBC·Jul 20, 2026·1 min readSamsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash dealSamsung Biologics acquires PolyPeptide Group for 2.7 trillion won ($1.8 billion)View original source — CNBC ↗ShareCopy linkShare on XShare on FacebookRelated storiesPhilippine Daily InquirerBusinessJul 20, 2026 · 1 minChildhood dev’t should top Sona education agenda – groupPhilippine Daily InquirerCNBCBusinessJul 20, 2026 · 1 minTrump imposing 50% tariffs on certain Canadian goods over alleged trade discriminationCNBCMarketWatchBusinessJul 20, 2026 · 1 minLumentum’s stock just got a lot more interesting — and Barclays has turned bullishMarketWatchCNABusinessJul 20, 2026 · 1 minSamsung launches first US credit card with Barclays, signals ambitions for deeper financial services pushCNA
Philippine Daily InquirerBusinessJul 20, 2026 · 1 minChildhood dev’t should top Sona education agenda – groupPhilippine Daily Inquirer
CNBCBusinessJul 20, 2026 · 1 minTrump imposing 50% tariffs on certain Canadian goods over alleged trade discriminationCNBC
MarketWatchBusinessJul 20, 2026 · 1 minLumentum’s stock just got a lot more interesting — and Barclays has turned bullishMarketWatch
CNABusinessJul 20, 2026 · 1 minSamsung launches first US credit card with Barclays, signals ambitions for deeper financial services pushCNA